Fighting leukemia relapse with Donor's supercharged immune cells
Disease control
Terminated
This study tested whether specially prepared immune cells from a stem cell donor could help patients with acute myeloid leukemia (AML) after their transplant. The cells, called MT-401, were given to try to prevent the cancer from coming back or to treat it if it did return. The t…
Phase: PHASE2 • Sponsor: Marker Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC